- Home
- TAK vs OTIS Comparison
TAK vs OTIS Comparison
Compare TAK & OTIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TAK | OTIS |
|---|---|---|
| Founded | 1781 | 1853 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Consumer Electronics/Appliances |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.3B | 35.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TAK | OTIS |
|---|---|---|
| Price | $16.42 | $89.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $103.50 |
| AVG Volume (30 Days) | 2.6M | ★ 2.6M |
| Earning Date | 01-29-2026 | 01-28-2026 |
| Dividend Yield | ★ 3.30% | 1.87% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.14 | ★ 3.39 |
| Revenue | ★ $29,846,840,032.00 | $14,310,000,000.00 |
| Revenue This Year | N/A | $3.74 |
| Revenue Next Year | $0.47 | $4.94 |
| P/E Ratio | $114.91 | ★ $26.50 |
| Revenue Growth | N/A | ★ 0.73 |
| 52 Week Low | $12.80 | $84.25 |
| 52 Week High | $16.42 | $106.83 |
Technical Indicators
Market Signals| Indicator | TAK | OTIS |
|---|---|---|
| Relative Strength Index (RSI) | 73.77 | 56.36 |
| Support Level | $15.87 | $88.87 |
| Resistance Level | $16.40 | $90.95 |
| Average True Range (ATR) | 0.18 | 1.34 |
| MACD | 0.04 | 0.23 |
| Stochastic Oscillator | 93.47 | 76.19 |
Price Performance
Historical ComparisonAbout TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About OTIS Otis Worldwide Corporation
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.